PCSK9 Inhibitors - Alirocumab and Evolucumab- Key Insights on Differentiation in a Generic Market

May 1, 2016, 00:00
10.1016/j.jval.2016.03.152
https://www.valueinhealthjournal.com/article/S1098-3015(16)00220-5/fulltext
Title : PCSK9 Inhibitors - Alirocumab and Evolucumab- Key Insights on Differentiation in a Generic Market
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)00220-5&doi=10.1016/j.jval.2016.03.152
First page : A57
Section Title : Cardiovascular Disorders - Health Care Use & Policy Studies
Open access? : No
Section Order : 1500
Categories :
Tags :
Regions :
ViH Article Tags :